GE HealthCare Technologies (NASDAQ:GEHC) Releases FY 2026 Earnings Guidance

GE HealthCare Technologies (NASDAQ:GEHC) updated its FY 2026 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of 4.800-5.000 for the period, compared to the consensus EPS estimate of 4.870. The company issued revenue guidance of -. GE HealthCare Technologies also updated its Q2 2026 guidance to EPS.

Wall Street Analyst Weigh In

A number of research firms have issued reports on GEHC. Zacks Research cut GE HealthCare Technologies from a “hold” rating to a “strong sell” rating in a research note on Tuesday. Rothschild & Co Redburn dropped their price objective on shares of GE HealthCare Technologies from $110.00 to $98.00 in a report on Thursday, April 30th. Weiss Ratings downgraded shares of GE HealthCare Technologies from a “hold (c)” rating to a “hold (c-)” rating in a research report on Friday, May 15th. UBS Group decreased their target price on shares of GE HealthCare Technologies from $69.00 to $67.00 and set a “neutral” rating for the company in a research report on Thursday, July 16th. Finally, Jefferies Financial Group dropped their price target on shares of GE HealthCare Technologies from $105.00 to $90.00 in a research note on Thursday, April 30th. Ten investment analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $76.41.

GE HealthCare Technologies Price Performance

GEHC traded up $0.58 during trading on Thursday, reaching $61.99. The stock had a trading volume of 4,459,152 shares, compared to its average volume of 4,441,284. The stock has a 50 day moving average of $63.65 and a two-hundred day moving average of $71.46. The company has a quick ratio of 0.95, a current ratio of 1.22 and a debt-to-equity ratio of 0.95. The firm has a market capitalization of $28.20 billion, a price-to-earnings ratio of 14.83, a price-to-earnings-growth ratio of 1.69 and a beta of 0.72. GE HealthCare Technologies has a 1-year low of $58.75 and a 1-year high of $89.77.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings data on Wednesday, April 29th. The company reported $0.99 earnings per share for the quarter, missing the consensus estimate of $1.07 by ($0.08). The firm had revenue of $5.13 billion during the quarter, compared to analyst estimates of $5.04 billion. GE HealthCare Technologies had a net margin of 9.10% and a return on equity of 20.46%. The company’s quarterly revenue was up 7.4% compared to the same quarter last year. During the same quarter last year, the company earned $1.01 EPS. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. As a group, equities analysts anticipate that GE HealthCare Technologies will post 4.89 EPS for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, August 14th. Stockholders of record on Friday, July 24th will be paid a $0.035 dividend. The ex-dividend date of this dividend is Friday, July 24th. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. GE HealthCare Technologies’s payout ratio is currently 3.35%.

Insiders Place Their Bets

In related news, CFO James Saccaro bought 3,310 shares of the business’s stock in a transaction dated Friday, May 1st. The shares were bought at an average cost of $60.60 per share, with a total value of $200,586.00. Following the completion of the transaction, the chief financial officer directly owned 87,471 shares of the company’s stock, valued at approximately $5,300,742.60. This trade represents a 3.93% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, Director Rodney F. Hochman purchased 1,618 shares of the firm’s stock in a transaction that occurred on Tuesday, May 12th. The stock was bought at an average price of $62.03 per share, with a total value of $100,364.54. Following the transaction, the director directly owned 1,618 shares in the company, valued at $100,364.54. This trade represents a ∞ increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Over the last three months, insiders purchased 21,847 shares of company stock worth $1,361,355. Company insiders own 0.36% of the company’s stock.

Institutional Investors Weigh In On GE HealthCare Technologies

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Empowered Funds LLC lifted its stake in GE HealthCare Technologies by 6.1% in the first quarter. Empowered Funds LLC now owns 28,848 shares of the company’s stock valued at $2,328,000 after acquiring an additional 1,665 shares during the last quarter. Acadian Asset Management LLC acquired a new stake in shares of GE HealthCare Technologies in the first quarter worth about $259,000. Cresset Asset Management LLC lifted its position in shares of GE HealthCare Technologies by 12.5% in the second quarter. Cresset Asset Management LLC now owns 7,802 shares of the company’s stock worth $578,000 after buying an additional 865 shares during the last quarter. Jump Financial LLC increased its holdings in shares of GE HealthCare Technologies by 317.6% during the 2nd quarter. Jump Financial LLC now owns 28,132 shares of the company’s stock valued at $2,084,000 after acquiring an additional 21,396 shares during the last quarter. Finally, Gamco Investors INC. ET AL raised its stake in shares of GE HealthCare Technologies by 8.6% in the 2nd quarter. Gamco Investors INC. ET AL now owns 4,041 shares of the company’s stock valued at $299,000 after acquiring an additional 320 shares in the last quarter. Hedge funds and other institutional investors own 82.06% of the company’s stock.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.